Identification, characterization and control of a sequence variant in monoclonal antibody drug product: a case study
Abstract Sequence variants (SV) in protein bio therapeutics can be categorized as unwanted impurities and may raise serious concerns in efficacy and safety of the product. Early detection of specific sequence modifications, that can result in altered physicochemical and or biological properties, is...
Enregistré dans:
| Auteurs principaux: | , , , , , , , , , , , |
|---|---|
| Format: | article |
| Langue: | EN |
| Publié: |
Nature Portfolio
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/5e77fcb98c3d4da6a2b92852977e8e65 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|